A clinical study to compare which has better pain relief pericapsular nerve group block versus suprainguinal fascia iliaca block after the surgery in patients undergoing hip surgery.

Compare analgesic efficacy of USG guided pericapsular nerve group block versus suprainguinal fascia iliaca block for post operative pain relief in hip surgery - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070165

Enrollment

Registered

2024-07-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Suprainguinal fascia iliaca block: Group B will receive suprainguinal fascia iliaca block, 20 ml 0.5% bupivacaine after the hip surgery Intervention2: Pericapsular nerve group block (PE

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1-3,Patients scheduled for unilateral hip surgery

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. Surgery more than 150 min 3. Coagulation or bleeding disorder 4. Allergy to local anaesthetics 5. Presence of other fracture requiring surgery 6. Morbid obesity 7. Pre-existing uncontrolled cardiovascular disease, renal failure, hepatic failure

Design outcomes

Primary

Measure	Time frame
Duration of pain relief assessmentTimepoint: Time to first requirement of analgesics will be noted post operative till 24hours	—

Secondary

Measure	Time frame
1. Total analgesic requirement in 24 hrs postoperatively. 2.Intensity of pain relief assessment by VAS score at 0,2,4,8,12,24 hours. 3. Patients satisfaction score. 4. Incidence of failed block. 5. Incidence of procedure and drug related complications.Timepoint: Intensity of pain relief assessment by VAS score at 0,2,4,8,12,24 hours.	—

Countries

India

Contacts

Public ContactSimran Rana

Pt JNM Medical College Raipur CG

prati_jain@rediffmail.com9827276620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026